"Patients who are mild-to-moderately agitated in whom there is the potential for escalation to more severe agitation," are good candidates for sublingual dexmedetomidine, Preskorn told Medscape Medical News.
https://www.medscape.com/viewarticle/969320?spon=12&uac=392623PN&impID=4056511&sso=true&faf=1&src=WNL_mdpls_220301_mscpedit_psych
Comments